European Consensus for Diagnosis of MCI and Mild Dementia

The EANM, represented by Silvia Morbelli and Valentina Garibotto from the Neuroimaging Committee, is taking part in a European Inter-Societal Consensus initiative aimed at defining a workflow for the use of biomarkers in the etiological diagnosis of neurocognitive disorders in MCI and mild dementia stages. The task force, encompassing eleven European scientific societies, used the Delphi consensus and a systematic literature review to define the final workflow, which was agreed upon in June. The first paper describing the preparatory phase of the consensus has now been published:

          Alzheimer’s Dement (2022)

This website uses cookies. Learn more